Medical device manufacturer Phillips Medisize unveils TheraVolt Medical Connectors, designed for seamless integration with upcoming medical devices.
Phillips Medisize, a Molex company, has unveiled TheraVolt Medical Connectors, a new innovation aimed at addressing the growing demands for advanced medical device connectivity in electrophysiology. These connectors offer several notable advantages, including next-generation device integration, improved connectivity, and optimized device performance.
TheraVolt connectors are designed to enable seamless integration with modern electrophysiology devices, enhancing connectivity capabilities essential for advanced diagnostics and treatment tools. They provide reliable, high-performance electrical connections, ensuring consistent data transmission and device function.
The connectors are engineered to support innovation and customization, aligning with Phillips Medisize’s broader commitment to medical device innovation. This adaptability allows for tailoring to emerging technology needs. Furthermore, TheraVolt connectors are backed by a robust medical device support framework, leveraging Phillips Medisize’s expertise in semi-finished and finished components for medical applications.
One of the key features of TheraVolt connectors is their ability to withstand multiple autoclave cycles, maintaining integrity and performance even under repeated exposure to harsh sterilisation processes. This sterilisation compatibility is a significant advantage, ensuring these connectors can be used in a wide range of medical applications.
TheraVolt offers solutions for handling both signals and high voltage lines, making it suitable for a variety of medical devices. The connectors are also designed to provide enhanced cross-platform compatibility, simplifying medical device integration.
The demand for advanced medical connectors is increasing due to trends in electrophysiology, particularly the rapid adoption of pulsed field ablation technology. High pin count and voltage clearance enable the integration of more functionalities, allowing for the design of multi-therapy medical devices with expanded capabilities, advanced functions, and increased data collection.
TheraVolt Medical Connectors can enable more efficient solutions and greater flexibility for medical device companies developing PFA treatment for atrial fibrillation patients. By simplifying medical device integration, increasing the longevity of capital equipment, reducing customization development time, and lowering costs, TheraVolt is poised to revolutionize the electrophysiology sector.
Pete Soupir, vice president of MedTech segment at Phillips Medisize, expressed excitement about the launch of TheraVolt, stating that it has the potential to bring deeper collaboration and innovation to their medtech customers.
To learn more about TheraVolt Medical Connectors, visit molex.com and phillipsmedisize.com. Additionally, Phillips Medisize is developing further medical connectors, with more solutions expected to be delivered over the next 18-24 months.
TheraVolt Medical Connectors, designed by Phillips Medisize, are not only suitable for various medical devices due to their ability to handle both signals and high voltage lines, but they also offer enhanced cross-platform compatibility, simplifying medical device integration. This technology aligns with Phillips Medisize’s broader commitment to medical device innovation and data-and-cloud-computing, as they are backed by a robust medical device support framework and engineered to support innovation and customization. These connectors are significant in the rapidly advancing field of medical devices and medical plastics, particularly in electrophysiology as they enable the integration of more functionalities and facilitate the design of multi-therapy medical devices.
